Zai Lab

$87.20
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.51 (+0.59%) Today
$0.00 (0.00%) As of 5:47 AM EDT after-hours

Why Robinhood?

You can buy or sell Zai Lab and other stocks, options, and ETFs commission-free!

About ZLAB

Zai Lab Limited American Depositary Shares, also called Zai Lab, is a biopharmaceutical company. It engages in the discovering, licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need in the fields of oncology, infectious and autoimmune diseases. Read More The company's products include Zejula and Optune. Zai Lab was founded by Samantha Ying Du and Marietta Wu in April 2014 and is headquartered in Shanghai, China. The listed name for ZLAB is Zai Lab Limited American Depositary Shares.

Employees
692
Headquarters
Shanghai, Shanghai
Founded
2014
Market Cap
7.49B
Price-Earnings Ratio
Dividend Yield
Average Volume
263.27K
High Today
$87.36
Low Today
$84.56
Open Price
$86.79
Volume
159.78K
52 Week High
$95.52
52 Week Low
$30.01

Collections

ZLAB Earnings

-$1.37
-$0.91
-$0.46
$0.00
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q4 2020
Estimated
per share
Actual
Expected Feb 5, Pre-Market

You May Also Like